News
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological ...
People with Williams Syndrome treat strangers as their new best friends. Now the condition is revealing clues to our ...
MediaTek has announced the launch of its T930 chipset designed for 5G Fixed Wireless Access (FWA) and mobile Wi-Fi (Mi-Fi) ...
Data support planned dosing regimen and protocol for FIH study to initiate in mid-2025LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Axovia Therapeutics Ltd., a biotechnology company developing therapies to ...
New breakthrough data from studies with Coave’s ALIGATER™-engineered AAV2-based capsid coAAV-CSF-01 (S01coAAV2) demonstrates improved brain tissue transduction and safety following intra-cerebrospinal ...
Discover how nighttime wakefulness triggers DNA damage, metabolic chaos, and brain deterioration that accelerates aging and ...
Realme GT 7 Series set to launch on 27 May, confirmed to feature the powerful Dimensity 9400e chipset for enhanced ...
Challenging the notion of inevitable cognitive decline, research suggests that engaging in new skills after 60 can ...
Set to revolutionize 5G Fixed Wireless Access and AI-enabled networks with cutting-edge features like 3GPP Release 18 support ...
Have you ever been stuck on a problem, puzzling over something for what felt like ages without getting anywhere, but then suddenly the answer came to you like a bolt from the blue?
Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today announced the results of preclinical studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results